The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Myosin inhibitors failed to improve outcomes in the phase 3 ODYSSEY-HCM trial in patients with non-obstructive hypertrophic cardiomyopathy.
“Despite their success in obstructive HCM, myosin inhibitors failed to improve outcomes in the recent phase 3 ODYSSEY-HCM trial, underscoring the lack of effective therapies for nHCM [2,3].”
From Association of GLP-1 receptor agonist use with cardiovascular outcomes in patients with non-obstructive hypertrophic cardiomyopathy (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Flagged first, then by citations
Research works printed but not linked: 27
- 10.1093/eurheartj/ehad194 · DOI · Paper page
- 10.1016/j.jacc.2021.12.002 · DOI · Paper page
- 10.1016/j.amjcard.2023.10.074 · DOI
- 10.1016/j.pcad.2023.08.006 · DOI
- 10.1016/j.jacc.2016.07.758 · DOI
- 10.1016/j.jacc.2022.04.048 · DOI
- 10.1016/S0140-6736(20)31792-X · DOI · Paper page
- 10.1001/jamacardio.2023.3030 · DOI
- 10.1161/CIRCIMAGING.122.014986 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.122.062534 · DOI
- 10.1001/jamacardio.2023.3342 · DOI
- 10.1016/j.jacc.2021.09.1381 · DOI
- 10.1016/j.jchf.2023.09.028 · DOI
- 10.1016/S0140-6736(21)00763-7 · DOI · Paper page
- 10.1161/CIRCIMAGING.124.017185 · DOI
- 10.1016/j.jacc.2024.06.025 · DOI
- 10.1016/j.jcmg.2024.08.005 · DOI
- 10.1093/eurheartj/ehae579 · DOI · Paper page
- 10.1016/j.jacc.2020.03.064 · DOI
- 10.1016/j.jchf.2024.11.013 · DOI
- 10.1056/NEJMoa2401424 · DOI · Paper page
- 10.1016/j.jacc.2020.08.045 · DOI · Paper page
- 10.1371/journal.pone.0168407 · DOI
- 10.1016/j.jacc.2021.11.021 · DOI
- 10.1016/j.jcmg.2013.08.010 · DOI
- 10.1161/CIRCULATIONAHA.106.644682 · DOI
- 10.1016/j.jtcvs.2020.12.016 · DOI
Cited by
Sorted by citations
Bal, H. S., Nayak, A., Pampana, A., Malay, S., Upadhyaya, A., Vekariya, N., Arora, G., & Arora, P. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101451
Metadata
- Authors
- Desai, M. Y., Owens, A. T., Abraham, T., Olivotto, I., Garcia-Pavia, P., Lopes, R. D., Elliott, P., Fernandes, F., Verheyen, N., Maier, L., Meder, B., Azevedo, O., Kitaoka, H., Wolski, K., Wang, Q., Jaber, W., Mitchell, L., Myers, J., Rano, T., Gong, Z., Zhong, Y., Carter-Bonanza, S., Florea, V., Aronson, R., & Nissen, S. E.
- Affiliations
- Hypertrophic Cardiomyopathy Center, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland
- Department of Cardiology, University of Pennsylvania, Philadelphia
- Department of Cardiology, University of, California, San Francisco, San Francisco
- Department of Cardiology, Meyer Children’s Hospital, IRCCS, Florence, Italy
- Department of Cardiology, Hospital Universitario Puerta de Hierro, Instituto de Investigación Sanitaria Puerta de Hierro–Segovia de Arana, Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, and Centro Nacional de Investigaciones Cardiovasculares, Madrid
- Department of Cardiology, Duke University, Durham, NC
- Institute of Cardiovascular Science, University College, London
- Instituto do Coração–Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paolo
- Department of Cardiology, Medical University of Graz, Graz, Austria
- Department of Cardiology, University Clinic Regensburg, Regensburg, Germany
- Department of Cardiology, University Clinic Heidelberg, Heidelberg, Germany
- Department of Cardiology, Unidade Local de Saúde do Alto Ave, EPE–Hospital da Senhora da Oliveira Guimarães, Guimarães, Portugal
- Department of Cardiology, Kochi Medical School Hospital, Kochi, Japan
- Cleveland Clinic Coordinating Center for Clinical Research, Heart Vascular Thoracic Institute, Cleveland Clinic, Cleveland
- Veterans Affairs Palo Alto Medical Center and Stanford University, Palo Alto, CA
- Bristol Myers Squibb, Princeton, NJ
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2025-09-11
- Volume
- 393
- Issue
- 10
- Pages
- 961-972
- ISSN
- 0028-4793
- 1533-4406
- Cited by
- 90
- References
- 1
- Language
- en
- Funders
- Bristol Myers Squibb Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
